Literature DB >> 2506606

Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats.

A C Santucci1, P D Kanof, V Haroutunian.   

Abstract

The efficacy of physostigmine on memory enhancement in rats trained on a passive avoidance task was investigated. In experiment 1, the effect of posttraining injections of physostigmine (0.03 mg/kg) in subjects tested at either short (1.25 h or 72 h) or long (3 weeks or 5 weeks) retention intervals was explored. Results indicated drug-induced enhancement of memory at only the two short intervals. Experiment 2 examined the mnemonic consequences of pretest administration of physostigmine. Administration of physostigmine (0.015 mg/kg and 0.03 mg/kg) shortly prior to testing led to a significant potentiation of memory retrieval. The aim of experiment 3 was to determine whether or not an intact cholinergic system is necessary for pretest physostigmine to enhance memory retrieval. Results from this experiment indicated that physostigmine (0.03 mg/kg) was effective in enhancing memory in rats prepared with ibotenic acid-induced lesions of the nucleus basalis of Meynert. Together, these data provide further empirical support for the importance of the cholinergic system in memory processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506606     DOI: 10.1007/bf00634455

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Influence of physostigmine upon consolidation of memory in mice.

Authors:  A Signorelli
Journal:  J Comp Physiol Psychol       Date:  1976-07

2.  Nucleus basalis lesions impair memory in rats trained on nonspatial and spatial discrimination tasks.

Authors:  A C Santucci; V Haroutunian
Journal:  Physiol Behav       Date:  1989-05

3.  Influence of recall on an anticholinesterase induced retrograde amnesia.

Authors:  M D Hamburg; D R Fulton
Journal:  Physiol Behav       Date:  1972-09

4.  Amnesic effects of scopolamine.

Authors:  S D Glick; B Zimmerberg
Journal:  Behav Biol       Date:  1972-04

5.  The effects of scopolamine hydrobromide on one-way and two-way avoidance learning in rats.

Authors:  E Suits; R L Isaacson
Journal:  Int J Neuropharmacol       Date:  1968-09

6.  Pharmacological alleviation of cholinergic lesion induced memory deficits in rats.

Authors:  V Haroutunian; P Kanof; K L Davis
Journal:  Life Sci       Date:  1985-09-09       Impact factor: 5.037

7.  Cholinergic receptor interactions and their effects on long-term memory processing.

Authors:  J F Flood; D W Landry; M E Jarvik
Journal:  Brain Res       Date:  1981-06-29       Impact factor: 3.252

Review 8.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

9.  Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: a review and some new results.

Authors:  G Bammer
Journal:  Neurosci Biobehav Rev       Date:  1982       Impact factor: 8.989

10.  Cholinergic receptor blockade impairs spatial localization by use of distal cues in the rat.

Authors:  R J Sutherland; I Q Whishaw; J C Regehr
Journal:  J Comp Physiol Psychol       Date:  1982-08
View more
  9 in total

1.  Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation.

Authors:  Steffen Gais; Jan Born
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

2.  Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors.

Authors:  J Winkler; G A Ramirez; L J Thal; J J Waite
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

Review 3.  Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.

Authors:  Mrinmay Chakrabarti; Alexander J McDonald; J Will Reed; Melissa A Moss; Bhaskar C Das; Swapan K Ray
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 4.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Memory modulation with peripherally acting cholinergic drugs.

Authors:  D K Rush; K Streit
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation.

Authors:  Jos Prickaerts; Ayhan Sik; Franz Josef van der Staay; Jan de Vente; Arjan Blokland
Journal:  Psychopharmacology (Berl)       Date:  2004-07-24       Impact factor: 4.530

7.  Velnacrine maleate improves delayed matching performance by aged monkeys.

Authors:  W J Jackson; J J Buccafusco; A V Terry; D J Turk; D K Rush
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

Review 8.  Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials.

Authors:  Qiutian Jia; Yulin Deng; Hong Qing
Journal:  Biomed Res Int       Date:  2014-07-17       Impact factor: 3.411

Review 9.  Therapeutic insights elaborating the potential of retinoids in Alzheimer's disease.

Authors:  Tapan Behl; Dapinder Kaur; Aayush Sehgal; Rajeev K Singla; Hafiz A Makeen; Mohammed Albratty; Hassan A Alhazmi; Abdulkarim M Meraya; Simona Bungau
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.